FLT3 and precursor B-cell acute lymphoblastic leukemia: We identified evidence that FLT3 may be a marker influencing the biological behavior of B-ALL, reinforcing the need for more in-depth studies to better elucidate FLT3's relationship with mechanisms involved in the genesis, survival, or resistance of leukemic cells to chemotherapeutic effects: 1.